Research-Grade Peptide
Tirzepatide
A dual GIP/GLP-1 receptor agonist studied as a reference compound in metabolic-regulation models.
Pre-Order
This size isn't in stock right now. Join the list and we'll contact you the moment it lands.
- ✓ ≥ 99% purity by HPLC
- ✓ Third-party tested in Canada, COA on every batch
- ✓ Discreet, tracked shipping · free over $250
A dual GIP/GLP-1 receptor agonist studied as a reference compound in metabolic-regulation models.
Further reading: Tirzepatide on The Peptide Guide — an independent Canadian reference with compound profiles and a reconstitution calculator. Educational only; nothing there is a statement about this product.
Research background
Tirzepatide is a synthetic peptide that binds two receptors — GIP and GLP-1 — a dual-agonist design that distinguishes it from single-receptor compounds and preceded the triple agonists now under investigation. Research examines receptor binding and downstream metabolic signalling, and it is frequently used as a comparator when evaluating newer multi-receptor candidates. Tirzepatide is the subject of a separate pharmaceutical development programme and approved clinical products; that work belongs to its developers and does not describe material supplied for laboratory research. Research Use Only. Not for human or veterinary use.
Supplied as a lyophilised powder for laboratory research use only. Any context described above refers to published preclinical or in-vitro research — not to human or veterinary use.